Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019-20.

• Main Authors: Devika Shanmugasundaram (Author), Shally Awasthi (Author), Bhagirathi Dwibedi (Author), S Geetha (Author), Manish Jain (Author), Shikha Malik (Author), Bhupeshwari Patel (Author), Himabindu Singh (Author), Shalini Tripathi (Author), Rajlakshmi Viswanathan (Author), Anjoo Agarwal (Author), Rajeswari Bonu (Author), Shuchi Jain (Author), Saubhagya Kumar Jena (Author), J Priyasree (Author), K Pushpalatha (Author), Syed Ali (Author), Debasis Biswas (Author), Amita Jain (Author), Rahul Narang (Author), Sudha Madhuri (Author), Suji George (Author), Ojas Kaduskar (Author), G Kiruthika (Author), R Sabarinathan (Author), Gajanan Sapakal (Author), Nivedita Gupta (Author), Manoj V Murhekar (Author)
• פורמט: ספר
• יצא לאור: Public Library of Science (PLoS), 2021-07-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

<h4>Background</h4>India has set a goal to eliminate measles and rubella/Congenital Rubella Syndrome (CRS) by 2023. Towards this goal, India conducted nationwide supplementary immunization activity (SIA) with measles-rubella containing vaccine (MRCV) targeting children aged between 9 mon...